[Pharmacological studies on bimolane (AT-1727), a new antineoplastic agent (author's transl)].
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D004285:Dogs; D007109:Immunity / Q000187:drug effects; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D011929:Razoxane / Q000031:analogs & derivatives / Q000494:pharmacology*
D000970:Antineoplastic Agents; D010879:Piperazines; C031186:bimolane; D011929:Razoxane